These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2631821)

  • 41. [External graphic recording devices in the evaluation of ischemic cardiopathy].
    Fishleder BL
    Arch Inst Cardiol Mex; 1980; 50(3):391-9. PubMed ID: 7425756
    [No Abstract]   [Full Text] [Related]  

  • 42. [Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
    Verdecchia P
    Clin Ter; 1982 Apr; 101(2):179-94. PubMed ID: 7047054
    [No Abstract]   [Full Text] [Related]  

  • 43. [Research on the interrelations between latent diabetes mellitus and painful ischemic cardiopathy].
    Gligore V; Lucaciu O; Rub D
    Med Interna (Bucur); 1966 Aug; 18(8):913-21. PubMed ID: 5975328
    [No Abstract]   [Full Text] [Related]  

  • 44. [Acute hemodynamic and cineangiographic effects of propatyl nitrate in symptomatic ischemic cardiopathy].
    Manfroi WC; Koppe V; Vieira SR; Goldim JR; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1987 Mar; 48(3):147-51. PubMed ID: 3314809
    [No Abstract]   [Full Text] [Related]  

  • 45. [Relation between hypothyroidism and chronic ischemic cardiopathy].
    Câmpeanu A; Nicolaescu V; Patrichi D; Popa A
    Med Interna (Bucur); 1973 May; 25(5):603-17. PubMed ID: 4793893
    [No Abstract]   [Full Text] [Related]  

  • 46. [Epidemiological studies of ischemic cardiopathy in industry. Effect of mental strain and intellectual work].
    Teculescu D; Lilis R; Hilt M; Rovenţa A
    Stud Cercet Med Interna; 1972; 13(3):259-74. PubMed ID: 4403614
    [No Abstract]   [Full Text] [Related]  

  • 47. [Minor disorders of carbohydrate metabolism as a risk factor in chronic ischemic cardiopathy].
    Fica V; Sdrobici D; Olteanu D; Stănescu L; Andronescu D; Brătănescu S; Enache M; Oprescu S; Serban M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(6):427-34. PubMed ID: 6121361
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thyroid function in chronic ischemic cardiopathy in adult and aged patients. I].
    Dumitru M
    Stud Cercet Endocrinol; 1973; 24(4):291-8. PubMed ID: 4720317
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rehabilitation in ischemic cardiopathy. Is it fantasy or reality? Secondary prevention].
    Maroto Montero JM
    Rev Esp Cardiol; 1989 Jan; 42(1):49-64. PubMed ID: 2682822
    [No Abstract]   [Full Text] [Related]  

  • 50. [Lipid markers of ischemic cardiopathy risk in obese women].
    Alessandri C; Gizzi S; Laurenti O; Ventura C; Tullo MG; Peverini F; Cerbara R; De Mattia G
    Clin Ter; 1987 Jun; 121(6):467-9. PubMed ID: 2973882
    [No Abstract]   [Full Text] [Related]  

  • 51. [What future for the intensive coronary care unit without interventional hemodynamics?].
    Pinelli G; Carini G
    Ital Heart J Suppl; 2003 Aug; 4(8):691-2. PubMed ID: 14655466
    [No Abstract]   [Full Text] [Related]  

  • 52. Study on the detection and epidemiology of risk factors in ischemic cardiopathy in some localities of Bihor County.
    Pop E; Popa I; Bolcaş D; Micle T; Segal N; Negrău T; Serdült I; Sirca D; Pop V; Curteanu G
    Sante Publique (Bucur); 1983; 26(3):233-52. PubMed ID: 6676943
    [No Abstract]   [Full Text] [Related]  

  • 53. Coronary heart disease - aetiology, pathology, and clinical features.
    Goodinson SM
    Nursing (Lond); 1984 May; 2(25):732-6. PubMed ID: 6563462
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prostaglandins and ischemic cardiopathy].
    Patrono C; De Caterina R; Maseri A
    G Ital Cardiol; 1980; 10(10):1371-82. PubMed ID: 7016653
    [No Abstract]   [Full Text] [Related]  

  • 55. [Recommendations for secondary prevention of the clinical coronary cardiopathy].
    Rev Esp Cardiol; 1985; 38(1):14-20. PubMed ID: 2858911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of ventricular function by two-dimensional echocardiography in ischemic cardiopathy. Hemodynamic correlation].
    Asín Cardiel E; Martínez JI; Martín de Dios R; Fernández Palomeque C; Ruiz I; Rodríguez Rodrigo F; Marín E; Señor J
    Rev Esp Cardiol; 1983; 36(1):27-33. PubMed ID: 6878806
    [No Abstract]   [Full Text] [Related]  

  • 57. [Echocardiographic evaluation of the physiopathologic aspects of myocardial contraction in ischemic cardiopathy, in basal conditions and following provocation tests].
    Gastaldi L; Morello M; Casalucci D; Ribetto-Bruno M
    Cardiologia; 1987 Nov; 32(11):1359-65. PubMed ID: 3447705
    [No Abstract]   [Full Text] [Related]  

  • 58. [Platelets, thromboatherogenesis and ischemic cardiopathy].
    Batlouni M
    Arq Bras Cardiol; 1980 Jan; 34(1):45-52. PubMed ID: 6996649
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of flurbiprofen on the platelet function in patients with ischemic cardiopathy].
    Davì G; Riolo FP; Novo S; Custro N; Avellone G; Mattina A; Strano A
    Cardiologia; 1982 Oct; 27(10):953-61. PubMed ID: 6892383
    [No Abstract]   [Full Text] [Related]  

  • 60. [Trends in mortality due to ischemic cardiopathy in relation to 3 principal risk factors (hypertension, tobacco dependence and diet)].
    Cortina Greus P; Saiz Sánchez MC; Soriano Marqués S; Muñoz Guillén S; Sabater Pons A; Ibáñez Gadea LM
    Rev Sanid Hig Publica (Madr); 1983; 57(7-8):783-96. PubMed ID: 6680470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.